A recent New York Times article reported that “Chinese peptides” are fueling a gray-market biohacking trend in Silicon Valley, as tech workers buy unregulated compounds for weight loss and self-optimization. LegitScript research director Gerard Olson is featured saying online advertising of unauthorized peptide formulations grew nearly eightfold from 2022 to 2024, highlighting the scale of the market.
In a recent Healthcare Business Today article, RazorMetrics Chief Pharmacy Officer Ryan Czado says prescription cost barriers persist for low-income workers, who may abandon medications when out-of-pocket costs jump at the pharmacy.
In a recent Security Journal Americas feature, Trackforce’s Jeff DiDomenico says enterprise security teams are replacing paper-based workflows with real-time, centralized operations that blend on-site guards with remote surveillance and automation.
In a recent article in The AI Journal, Xray introduced Jira-native AI for test case and model generation powered by Sembi IQ that keeps humans in the loop for review and governance. The coverage highlights enterprise controls, data privacy, and faster paths from requirement to release.
Stablecoins are edging closer to mainstream banking rails as Swift builds a shared-ledger network with major banks to enable tokenized settlements. In a recent American Banker article, the network’s design around ISO 20022 data standards and broad bank participation is framed as a way to bring programmability and always-on settlement into traditional finance.
Cohere Health is expanding its clinical intelligence capabilities with the acquisition of ZignaAI and the launch of a Payment Integrity suite built for near real-time clinical and coding validation. A recent Forbes article highlights how the move aims to bring more transparency to claims oversight and shift reviews upstream to reduce friction between payers and providers.
To help fleets cut manual work around fuel and maintenance, Motive and Fleetio have deepened their integration to centralize fuel, maintenance, and telematics data. In coverage from Transport Topics, the companies point to new two-way syncs that streamline compliance, sharpen visibility, and give operators a clearer view of fuel and service spend.
AustinPx CSO Dave Miller, PhD, uses a recent BioPharm International conversation to spotlight earlier sponsor engagement, lifecycle-minded IP strategy, and high-science platforms like KinetiSol as pillars of “true co-development.” He positions modern CDMO partnerships as extensions of the sponsor team, from early design decisions through commercialization.
In a recent Pensions & Investments article, a new analysis highlights widespread “clunker” funds in corporate 401(k)s—costly options that trail cheaper alternatives and erode participant outcomes. The coverage notes that the review spanned tens of thousands of plans and urges sponsors to replace underperformers with lower-fee choices.
Elizabeth Hickman, CEO of AustinPx, recently shared her take on what really matters when choosing a CDMO partner. In this interview, she stresses that technical capability is a must, but it must go beyond what's written in a brochure. The CDMO’s real-world experience, systems, and ability to keep up with the fast pace of development should be the key differentiator.
